Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.
Alex BugaDavid G HarperTeryn N SapperParker N HydeBrandon FellRyan DickersonJusten T StonerMadison L KackleyChristopher D CrabtreeDrew D DeckerBradley T RobinsonGerald KrystalKatherine BinzelMaryam B LustbergJeff S VolekPublished in: PloS one (2024)
Women diagnosed with MBC undergoing chemotherapy can safely achieve and maintain nutritional ketosis, while improving body composition and insulin resistance, out to six months.
Keyphrases
- body composition
- metastatic breast cancer
- polycystic ovary syndrome
- insulin resistance
- resistance training
- randomized controlled trial
- bone mineral density
- healthcare
- study protocol
- early stage
- palliative care
- phase iii
- high fat diet
- metabolic syndrome
- clinical trial
- type diabetes
- physical activity
- phase ii
- weight loss
- locally advanced
- quality improvement
- skeletal muscle
- pregnancy outcomes
- squamous cell carcinoma
- cervical cancer screening
- affordable care act
- glycemic control
- pregnant women
- chronic pain
- breast cancer risk